Cost prediction models for the comparison of two groups.

Area of Science:

• Health Economics
• Biostatistics
• Clinical Trial Methodology

Background:

• Patient-specific cost data are often unavailable in trial-based economic evaluations.
• Cost prediction models using regression techniques are commonly employed to estimate patient costs.
• Existing models often neglect the variability of beta coefficients from measurement and sampling error.

Purpose of the Study:

• To present a method for estimating the variance of beta coefficients in cost prediction models.
• To incorporate this variance into the overall variance expression for mean costs by treatment group.
• To demonstrate the application of the proposed method with an example.

Main Methods:

• Utilizing multiple regression techniques on data from diagnosis-matched, non-trial patients.
• Modeling cost as a function of covariates observed in trial subjects (e.g., length of stay, procedures).
• Developing a statistical approach to estimate the variance attributable to beta coefficient variability.

Main Results:

• The proposed method provides a means to estimate the seldom-included variance of beta coefficients.
• This estimation enhances the precision of total cost calculations for individual patients.
• The example application illustrates the practical implementation and benefits of the method.

Conclusions:

• The developed method addresses a critical gap in cost prediction modeling for economic evaluations.
• Accurate variance estimation leads to more reliable cost-effectiveness analyses in clinical trials.
• This approach improves the robustness of economic evaluations when patient-level cost data are limited.